Skip to main content

Advertisement

Log in

In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene delivery

  • Original Article
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

Proper antigen presentation is paramount to the induction of effective and persistent antitumor immune responses. In a murine model of hepatic metastasis of colon cancer, we found that the numbers of in situ mature dendritic cells (DCs) and macrophages in tumor-infiltrating leukocytes (TILs) were significantly increased in mice treated with the combination therapy of herpes simplex virus thymidine kinase, interleukin 2, and GM-CSF genes when compared with control groups without GM-CSF treatment. Significantly higher levels of IFN-γ, MIP-1α, mIL-12, and GM-CSF were detected in the tumor after the combination therapy. T cells isolated from the combination therapy–treated mice exhibited higher ex vivo direct CTL activity than those from other treatment groups. Antigen-presenting cells (APCs) enriched from the TILs and liver of the combination therapy–treated mice induced higher levels of proliferation by the splenocytes from long-term surviving mice that had been cured of tumors at early time points (days 4 and 7) whereas significant APC activity was only observed in the spleen at the latter time point (day 7, 14) after the combination therapy. In contrast, APCs isolated from tk or tk + IL-2–treated mice did not induce any significant proliferation. Subcutaneous injection of fluorescence-labeled latex microspheres followed by the combination therapy showed a similar sequential trafficking of microspheres, day 4 after the combination therapy to tumor and day 14 to spleen. The results suggest that APCs recruited by intratumoral gene delivery of GM-CSF can capture antigens, mature to a stage suitable for antigen presentation, and subsequently migrate to the spleen where they can efficiently stimulate antigen-specific T cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3A–D.
Fig. 4A, B.
Fig. 5A–D.
Fig. 6A, B.

Similar content being viewed by others

References

  1. Armitage JO (1998) Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. Blood 92:4491

    CAS  PubMed  Google Scholar 

  2. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245

    CAS  PubMed  Google Scholar 

  3. Bradley LM, Watson SR, Swain SL (1994) Entry of naive CD4 T cells into peripheral lymph nodes requires L-selectin. J Exp Med 180:2401

    CAS  PubMed  Google Scholar 

  4. Caruso M, Pham-Nguyen K, Kwong YL, Xu B, Kosai KI, Finegold M, Woo SL, Chen SH (1996) Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. Proc Natl Acad Sci U S A 93:11302

    CAS  PubMed  Google Scholar 

  5. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J (1992) GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360:258

    CAS  PubMed  Google Scholar 

  6. Cella M, Sallusto F, Lanzavecchia A (1997) Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9:10

    CAS  PubMed  Google Scholar 

  7. Chen SH, Shine HD, Goodman JC, Grossman RG, Woo SL (1994) Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci U S A 91:3054

    CAS  PubMed  Google Scholar 

  8. Chen SH, Chen XH, Wang Y, Kosai K, Finegold MJ, Rich SS, Woo SL (1995) Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci U S A 92:2577

    CAS  PubMed  Google Scholar 

  9. Chen SH, Kosai K, Xu B, Pham-Nguyen K, Contant C, Finegold MJ, Woo SL (1996) Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival. Cancer Res 56:3758

    PubMed  Google Scholar 

  10. Chen SH, Pham-Nguyen KB, Martinet O, Huang Y, Yang W, Thung SN, Chen L, Mittler R, Woo SL (2000) Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4–1BB costimulation. Mol Ther 2:39

    CAS  PubMed  Google Scholar 

  11. Chiodoni C, Paglia P, Stoppacciaro A, Rodolfo M, Parenza M, Colombo MP (1999) Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response. J Exp Med 190:125

    CAS  PubMed  Google Scholar 

  12. Corbett TH, Griswold DP Jr, Roberts BJ, Peckham JC, Schabel FM Jr (1975) Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res 35:2434

    CAS  PubMed  Google Scholar 

  13. Curiel-Lewandrowski C, Mahnke K, Labeur M, Roters B, Schmidt W, Granstein RD, Luger TA, Schwarz T, Grabbe S (1999) Transfection of immature murine bone marrow-derived dendritic cells with the granulocyte-macrophage colony-stimulating factor gene potently enhances their in vivo antigen-presenting capacity. J Immunol 163:174

    CAS  PubMed  Google Scholar 

  14. Grabbe S, Beissert S, Schwarz T, Granstein RD (1995) Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? Immunol Today 16:117

    CAS  PubMed  Google Scholar 

  15. Grabbe s, s. Bruvers and R.D. Granstein (1992) Effects of immunomodulatory cytokines on the presentation of tumor-associated antigens by epidermal langerhans cells. J Invest Dermatol 98:66s

    PubMed  Google Scholar 

  16. Hellstrom KE, Hellstrom I, Chen L (1995) Can co-stimulated tumor immunity be therapeutically efficacious? Immunol Rev 145:123

    CAS  PubMed  Google Scholar 

  17. Kielian T, Nagai E, Ikubo A, Rasmussen CA, Suzuki T (1999) Granulocyte/macrophage-colony-stimulating factor released by adenovirally transduced CT26 cells leads to the local expression of macrophage inflammatory protein 1alpha and accumulation of dendritic cells at vaccination sites in vivo. Cancer Immunol Immunother 48:123

    Article  CAS  PubMed  Google Scholar 

  18. Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12:991

    CAS  PubMed  Google Scholar 

  19. Ribas A, Butterfield LH, Economou JS (2000) Genetic immunotherapy for cancer. Oncologist 5:87

    CAS  PubMed  Google Scholar 

  20. Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271

    PubMed  Google Scholar 

  21. Townsend SE, Allison JP (1993) Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 259:368

    Google Scholar 

Download references

Acknowledgements

The authors thank Drs Savio L.C. Woo, Simon Hall, Gwendalyn J. Randolph, and Celia Divino for helpful discussion; Ms Yunjuan Zang, Yongmei Gan, and Mr Khiem Pham-Nguyen for technical assistant; and Miss Marcia Messick for editorial assistance. This research was supported in part by the Sharp foundation and NIH grants RO1 75175, RO1 70337, and RO1 84404 to S.-H. Chen.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shu-Hsia Chen.

Additional information

P.-Y. Pan and Y. Li contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pan, PY., Li, Y., Li, Q. et al. In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene delivery. Cancer Immunol Immunother 53, 17–25 (2004). https://doi.org/10.1007/s00262-003-0417-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-003-0417-4

Keywords

Navigation